Carmel, IN, United States of America

Jeffrey Allen Peterson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Eli Lilly and Company. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Allen Peterson. Retrieved from https://idiyas.com/inventor/jeffrey-allen-peterson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jeffrey Allen Peterson: Innovator in Pharmaceutical Chemistry

Introduction

Jeffrey Allen Peterson is a notable inventor based in Carmel, IN (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address critical health issues.

Latest Patents

Peterson holds a patent for "Condensed thiophene derivatives useful as NaPi-IIb inhibitors." This invention provides compounds of the formula: (A), along with pharmaceutically acceptable salts and pharmaceutical compositions. These compounds are designed to treat hyperphosphatemia, chronic kidney disease, and cardiovascular diseases associated with chronic kidney disease. He has 1 patent to his name.

Career Highlights

Jeffrey Allen Peterson is associated with Eli Lilly and Company, a leading global pharmaceutical company. His work focuses on innovative solutions that enhance patient care and treatment outcomes.

Collaborations

Throughout his career, Peterson has collaborated with esteemed colleagues, including David Andrew Coates and Kevin Robert Fales. These partnerships have fostered a collaborative environment that promotes innovation and research.

Conclusion

Jeffrey Allen Peterson's contributions to pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work continues to pave the way for advancements in treating chronic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…